MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

28 Jan 2017 Evaluate

Fredun Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on February 13, 2017, to consider, approve and to take on records the Un-audited quarterly and nine monthly Financial Results for December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

1477.00 -70.75 (-4.57%)
17-Aug-2026 15:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1881.00
Dr. Reddys Labs. 1188.30
Cipla 1429.90
Lupin 2259.20
Zydus Lifesciences 1139.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: